Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;20 Suppl 2(Suppl 2):127-136.
doi: 10.1111/dom.13381.

Regulation of islet glucagon secretion: Beyond calcium

Affiliations
Review

Regulation of islet glucagon secretion: Beyond calcium

Jing W Hughes et al. Diabetes Obes Metab. 2018 Sep.

Abstract

The islet of Langerhans plays a key role in glucose homeostasis through regulated secretion of the hormones insulin and glucagon. Islet research has focused on the insulin-secreting β-cells, even though aberrant glucagon secretion from α-cells also contributes to the aetiology of diabetes. Despite its importance, the mechanisms controlling glucagon secretion remain controversial. Proper α-cell function requires the islet milieu, where β- and δ-cells drive and constrain α-cell dynamics. The response of glucagon to glucose is similar between isolated islets and that measured in vivo, so it appears that the glucose dependence requires only islet-intrinsic factors and not input from blood flow or the nervous system. Elevated intracellular free Ca2+ is needed for α-cell exocytosis, but interpreting Ca2+ data is tricky since it is heterogeneous among α-cells at all physiological glucose levels. Total Ca2+ activity in α-cells increases slightly with glucose, so Ca2+ may serve a permissive, rather than regulatory, role in glucagon secretion. On the other hand, cAMP is a more promising candidate for controlling glucagon secretion and is itself driven by paracrine signalling from β- and δ-cells. Another pathway, juxtacrine signalling through the α-cell EphA receptors, stimulated by β-cell ephrin ligands, leads to a tonic inhibition of glucagon secretion. We discuss potential combinations of Ca2+ , cAMP, paracrine and juxtacrine factors in the regulation of glucagon secretion, focusing on recent data in the literature that might unify the field towards a quantitative understanding of α-cell function.

Keywords: EphA receptor; cAMP; calcium; cellular heterogeneity; ephrin; glucagon; insulin; islet of Langerhans; microscopy; somatostatin; α-cell.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:

The authors have no conflict of interest to disclose.

Figures

Figure 1
Figure 1
Schematic of representative Ca2+ kymographs in 5 hypothetical β- and α-cells. The thickness of the line represents longer oscillatory duration. β-cells are electrically coupled and show synchronous behavior, triggered by glucose stimulation (A). In α-cells, cells show some synchronous activity, others stop oscillating, others remain unperturbed by the glucose stimulation (B). The different amplitudes and periodicity of these oscillations further contribute to the heterogeneity of the α-cell populations.
Figure 2
Figure 2
Isolated islets from a 27-year-old nondiabetic human donor. A) Tight junctions (arrows) between an alpha and beta cell. B) Multihormonal cell containing alpha cell granules (arrows), beta cell granules (arrowheads), and delta cell granules (*). Scale bar = 1 μm.

References

    1. MacDonald PE, Rorsman P. Oscillations, intercellular coupling, and insulin secretion in pancreatic beta cells. PLoS Biol. 2006;4:e49. - PMC - PubMed
    1. Hellman B, Salehi A, Gylfe E, Dansk H, Grapengiesser E. Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets. Endocrinology. 2009;150:5334–5340. - PubMed
    1. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003;284:E671–678. - PubMed
    1. Sutherland EW, de Duve C. Origin and Distribution of the Hyperglycemic-Glycogenolytic Factor of the Pancreas. J Biol Chem. 1948;175:663–674. - PubMed
    1. Greenbaum CJ, Prigeon RL, D’Alessio DA. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes. 2002;51:951–957. - PubMed

Publication types

MeSH terms